BioCentury | Jan 4, 2019
Financial News

Cellid proposes Korean IPO

...on E6 transforming protein (human papillomavirus-16; HpV16gp1), E7 transforming protein (human papillomavirus-18; HpV18gp2), HpV16gp2 and HpV18gp1...
BioCentury | Nov 9, 2018
Company News

Cue, LG in biologics deal

...IL-2 costimulatory factor linked to a T cell receptor targeting E6 transforming protein (human papillomavirus-18; HpV18gp1...
...LG Chem Ltd. (KRX:051910), Seoul, South Korea Business: Cancer Elizabeth S. Eaton CUE-101 Cue Biopharma Inc. LG Chem Ltd. E6 transforming protein (Human papillomavirus-18) (HpV18gp1...
BioCentury | Jan 5, 2018
Company News

Inovio, ApolloBio amend VGX-3100 deal

...targeting E6 transforming protein (Human papillomavirus-16; HpV16gp1), E7 transforming protein (Human papillomavirus-18; HpV18gp2), HpV16gp2 and HpV18gp1...
BioCentury | Sep 29, 2017
Financial News

Cue Biopharma proposes $40M IPO

...HpV18gp1). Cue Biopharma Inc. , Cambridge, Mass. Jennie Walters CUE-101 Albert Einstein College of Medicine Cue Biopharma Inc. E6 transforming protein (Human papillomavirus-18) (HpV18gp1...
BioCentury | Sep 22, 2017
Financial News

Cue Biopharma proposes $40M IPO

...an IL-2 co-stimulatory factor with a TCR targeting E6 transforming protein ( human papillomavirus-18 ; HpV18gp1). Jennie...
BioCentury | Jun 29, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: June 2017

...transforming protein (Human papillomavirus-18) (HpV18gp2) An immortalized human adult erythroid cell line overexpressing HpV18gp2 and HpV18gp1...
BioCentury | Jun 7, 2017
Distillery Techniques

Drug platforms

...marrow cells transduced with a tetracycline-inducible construct encoding E6 transforming protein ( human papillomavirus-18 ; HpV18gp1...
BioCentury | Feb 10, 2017
Emerging Company Profile

Improving the original immunotherapy

...Lead compounds CUE-101 and CUE-102 target a peptide derived from E6 transforming protein (human papillomavirus-18; HpV18gp1...
BioCentury | Jan 27, 2017
Finance

Activation on cue

...an IL-2 co-stimulatory factor with a TCR targeting E6 transforming protein ( human papillomavirus-18 ; HpV18gp1...
BioCentury | Jan 25, 2017
Financial News

Cue Biopharma launches, reveals funding

...CUE-101 links an IL-2 costimulatory factor with a TCR targeting E6 transforming protein (human papillomavirus-18; HpV18gp1...
Items per page:
1 - 10 of 13